Introduction
============

Mucosa-associated lymphoid tissue (MALT) lymphomas with t(1;14)(p22;q32) display a recurrent breakpoint upstream of *bcl10* that juxtaposes the gene under the control of the Ig heavy chain enhancer ([Willis et al. 1999](#Willisetal1999){ref-type="bib"}; [Zhang et al. 1999](#Zhangetal1999){ref-type="bib"}). As a consequence of this translocation, *bcl10* cDNAs from MALT lymphomas are overexpressed and contain a variety of mutations, mostly consisting of either nucleotide deletion or insertion, which result in truncations within or distal to the CARD ([Willis et al. 1999](#Willisetal1999){ref-type="bib"}; [Zhang et al. 1999](#Zhangetal1999){ref-type="bib"}). Thus, overexpression of truncated forms of bcl10, which retain constitutive NF-κB--inducing activity, transform primary rat embryonic fibroblasts ([Willis et al. 1999](#Willisetal1999){ref-type="bib"}). However, the mechanism by which deregulated expression of *bcl10* leads to cellular oncogenesis is currently not known.

Here, we show that bcl10 protein assemblates in cytoplasmic filaments that serve as scaffold for recruitment of NF-κB--activating signal transduction molecules. Cytochalasin D, a potent inhibitor of actin filament function, disassembles bcl10 filaments and specifically inhibits bcl10-induced NF-κB activation. Thus, assemblage of bcl10 in filaments connected to the cytoskeleton network is essential for bcl10-mediated NF-κB induction.

Materials and Methods
=====================

Cell Culture, Reagents and Luciferase Assay
-------------------------------------------

HeLa, HEK 293, and Rat-2 cells were cultured in DME 10% FCS. HeLa and Rat-2 cells were transfected using lipofectamine (GIBCO BRL); 293 cells were transfected by calcium phosphate precipitation. To assess NF-κB activation, HeLa and Rat-2 cells were transfected with 2 μg of the indicated cDNAs, together with pNF-κB-luc in 12-well plates. Cells were then lysed and luciferase activity was determined with the Luciferase Assay System (Promega). A plasmid expressing β-galactosidase was added to the transfection mixture for normalization of the efficiency of transfection. Cytochalasin D was obtained from Sigma Chemical Co.

Plamids Construction and Reagents
---------------------------------

PCR-based random mutagenesis of bcl10 was carried out in the following reaction buffer: 10 mM Tris-HCl, pH 8, 50 mM KCl, 0.5 mM MnCl~2~, 125 μM dNTPs. Reaction was performed using 2.5 U standard Taq polymerase, 200 ng of plasmidic template, and the oligos 5′-AAGAATTCCATGGAGCCCACCGCACC (forward) and 5′-AACTCGAGTCATGGAAAAGGTTCACAACTGCT (reverse). PCR products were purified and cloned in pcDNA3 expression vector (Invitrogen) provided with an HA epitope. The vectors pNF-κB-luc and pCMV-β-gal were from Clontech.

Immunofluorescence
------------------

HeLa cells were grown and transfected in chamber slides. 16 h after transfection, cells were fixed in 4% paraformaldehyde for 15 min at room temperature and then permeabilized in PBS/0.1% Triton X-100. Primary antibodies were incubated for 30 min in 5% FCS--PBS, followed by several washes with 5% FCS--PBS, and then incubating for 30 min with secondary antibody in 5% FCS--PBS. All steps were done at room temperature. Sources of antibodies and reagents for immunofluorescence were: anti-HA (Roche Molecular Biochemicals); anti-FLAG and anti--α-actinin (Sigma Chemical Co.); anti-TRADD and anti-RIP (Santa Cruz).

Two-Hybrid Screen and β-Gal Assays
----------------------------------

The two-hybrid screening was conducted using the Matchmaker system (Clontech) according to the manufacturer\'s instructions. In brief, yeast strain HF7c, expressing GAL4-DR4 fused protein, was transformed with a human peripheral blood leukocyte cDNA library cloned in the pGAD10 vector (Clontech) by lithium acetate/PEG 4000 procedure. 2 × 10^6^ clones were analyzed. Transformed yeast were selected on SD/agar plates lacking leucine, tryptophane, and histidine for 5 d at 30°C. Selected colonies were blotted on filter paper, permeabilized in liquid nitrogen, and placed on another filter soaked in Z buffer (60 mM Na~2~HPO~4~, 40 mM NaH~2~PO~4~, 10 mM KCl, 1mM MgSO~4~, and 37.5 mM β-mercaptoethanol) containing 1 mM 5-bromo-4-chloro-3-indolyl-β-[d]{.smallcaps}-galactoside. Colonies that developed color were restreaked on selective plates to allow plasmid segregation and tested again for β-galactosidase activity. The liquid β-galactosidase assay was performed according to the manufacturer\'s instructions using CPRG as substrate.

In Vitro Binding and Immunoblot Analysis
----------------------------------------

Recombinant histidine-tagged proteins were made in *Escherichia coli* BL21 strain using the pET expression system (Novagen). Proteins were purified with Ni-NTA agarose beads (Quiagen) and mixed with recombinant α-actinin (Sigma Chemical Co.) in E1A buffer (50 mM Hepes, 500 nM NaCl, 0.1% NP-40, and 10% glycerol). Samples were incubated for 1--2 h at 4°C, extensively washed by pulse centrifugation with E1A buffer and resuspended in 40 μl sample buffer. 5 μl of the reaction was loaded for SDS-PAGE and Western blot analysis.

Results and Discussion
======================

To determine the cellular localization of oncogenic bcl10, we transfected HeLa cells with an HA-tagged vector encoding the full-length bcl10, and the expressed protein was detected using a monoclonal anti-HA antibody. The results in [Fig. 1](#F1){ref-type="fig"} show that bcl10 exhibits a clear pattern of discrete and interconnecting cytoplasmic filaments resembling the death-effector filaments ([Perez and White 1998](#PerezandWhite1998){ref-type="bib"}; [Siegel et al. 1998](#Siegeletal1998){ref-type="bib"}). Similar filaments were observed when bcl10 was visualized using specific affinity-purified rabbit antisera raised against a bcl10-derived polypeptide ([Fig. 1](#F1){ref-type="fig"} D). The filaments were not an artifact of the staining procedure, since competition with the immunogenic peptide abolished the immunofluorescence (data not shown). Double-staining experiments indicated that bcl10 filaments partially overlap other cellular filaments, such as tubulin, keratin, and actin (data not shown).

The NH~2~-terminal region of bcl10 contains a CARD motif ([Costanzo et al. 1999](#Costanzoetal1999){ref-type="bib"}; [Koseki et al. 1999](#Kosekietal1999){ref-type="bib"}; [Srinivasula et al. 1999](#Srinivasulaetal1999){ref-type="bib"}; [Thome et al. 1999](#Thomeetal1999){ref-type="bib"}; [Willis et al. 1999](#Willisetal1999){ref-type="bib"}; [Yan et al. 1999](#Yanetal1999){ref-type="bib"}; [Zhang et al. 1999](#Zhangetal1999){ref-type="bib"}), which is both necessary and sufficient for NF-κB induction ([Costanzo et al. 1999](#Costanzoetal1999){ref-type="bib"}; [Koseki et al. 1999](#Kosekietal1999){ref-type="bib"}; [Willis et al. 1999](#Willisetal1999){ref-type="bib"}; [Zhang et al. 1999](#Zhangetal1999){ref-type="bib"}). To verify whether the CARD was involved in determining the filamentous arrangement of bcl10, we tested deleted versions of bcl10 for filament formation. A truncated bcl10 polypeptide (bcl10^128-233^) that lacks the CARD region showed a nonfilamentous diffuse distribution, whereas the CARD alone (bcl10^1-127^) formed filaments identical to the full-length protein ([Fig. 2](#F2){ref-type="fig"} A). Since the CARD of bcl10 retains the NF-κB--inducing activity, these experiments suggested a correlation between filaments formation and bcl10-mediated NF-κB activation. To further explore this possibility, we generated the point mutants bcl10(L41Q) and bcl10(G78R), because mutations of corresponding residues in the CARD of the cell death-inducing proteins, CED-3 and RAIDD, abrogate their functional activity ([Shaham and Horvitz 1996](#ShahamandHorvitz1996){ref-type="bib"}; [Duan and Dixit 1997](#DuanandDixit1997){ref-type="bib"}). Although expressed at levels comparable to the wild-type protein (data not shown), both mutants, bcl10(L41Q) and bcl10(G78R), did not form filaments and failed in activating NF-κB ([Fig. 2](#F2){ref-type="fig"} B).

bcl10 filament formation is not an effect of NF-κB activation because when bcl10 was cotransfected with dominant negative forms of IκB and NIK, which abrogate bcl10-induced NF-κB activation ([Costanzo et al. 1999](#Costanzoetal1999){ref-type="bib"}; [Koseki et al. 1999](#Kosekietal1999){ref-type="bib"}; [Srinivasula et al. 1999](#Srinivasulaetal1999){ref-type="bib"}), bcl10 filaments were formed ([Fig. 2](#F2){ref-type="fig"} C).

To determine whether bcl10 filaments are unequivocally linked to NF-κB activation, we generated a panel of random mutations in the CARD region of the protein. Microscopy and functional analysis of these mutants indeed revealed that only bcl10 mutants still able to form filaments could activate NF-κB ([Fig. 3](#F3){ref-type="fig"}).

Previously, we and others have shown that bcl10 activates NF-κB through a molecular pathway involved in tumor necrosis factor receptor 1 (TNF-R1) signaling ([Costanzo et al. 1999](#Costanzoetal1999){ref-type="bib"}; [Koseki et al. 1999](#Kosekietal1999){ref-type="bib"}; [Srinivasula et al. 1999](#Srinivasulaetal1999){ref-type="bib"}). To determine whether bcl10 filaments served as scaffolds for recruitment of signal transduction molecules, we performed double-staining experiments of bcl10 together with antibodies against proteins involved in TNF-RI signaling. [Fig. 4](#F4){ref-type="fig"} A shows that TRADD, an adapter molecule that is recruited to TNF-RI complex and signals NF-κB activation ([Hsu et al. 1995](#Hsuetal1995){ref-type="bib"}), localizes on bcl10 filaments. To determine whether TRADD could be actively recruited on bcl10 filaments, HeLa cells were left untreated or transfected with bcl10 and localization of endogenous TRADD was detected with anti-TRADD antibody by confocal microscopy. The results in [Fig. 4B](#F4){ref-type="fig"} and [Fig. C](#F4){ref-type="fig"}, show that whereas in untransfected cells, endogenous TRADD displays a diffuse cytoplasmic and nuclear distribution, expression of bcl10 results in translocation of cytoplasmic TRADD to bcl10 filaments. This observation is consistent with coprecipitation of TRADD with bcl10 ([Costanzo et al. 1999](#Costanzoetal1999){ref-type="bib"}), and implies that only filamentous organization of bcl10 allows recruitment of TRADD. The death domain-containing serine/threonine kinase RIP is essential for TNF-induced NF-κB signaling ([Kelliher et al. 1998](#Kelliheretal1998){ref-type="bib"}) and is recruited to TNF-R1 complex via interaction with TRADD ([Hsu et al. 1996](#Hsuetal1996){ref-type="bib"}). Similarly to TRADD, whereas in untransfected cells endogenous RIP displays a diffuse cytoplasmic localization (data not shown), expression of bcl10 results in translocation of RIP to bcl10 filaments ([Fig. 4](#F4){ref-type="fig"} D; and data not shown).

To assess whether cytoskeleton dynamics influence bcl10 activity, HeLa cells expressing bcl10 were treated with cytochalasin D, a potent inhibitor of actin filament function, and bcl10 localization was determined. As shown in [Fig. 5](#F5){ref-type="fig"}, cytochalasin D disassembles bcl10 filaments and specifically inhibits bcl10-induced NF-κB activation, whereas NF-κB activation induced by TNF stimulation or NIK overexpression is not affected. Thus, assemblage of bcl10 in filaments is essential for bcl10-mediated NF-κB induction.

bcl10 filament formation could either reflect an intrinsic property of that protein or be ordered via interactions with preexisting filamentous proteins. The observation that cytochalasin D disassembles bcl10 filaments prompted us to explore the possibility these filaments might be organized by CARD-mediated association with cytoskeletal components. To test for this, we performed a two-hybrid screen fusing the CARD of bcl10 to the DNA binding domain of GAL4 and searched a plasmid library of fusion between the GAL4 transcription activation domain and cDNAs from peripheral blood leukocytes. 13 independent clones were isolated that activated the β-galactosidase reporter gene when ∼2 × 10^6^ transformants were analyzed. Restriction mapping and partial sequencing of these 13 cDNAs revealed that six positive clones had the same ∼2-kb cDNA insert encoding for the polypeptide Pro^355^--Leu^892^ of α-actinin, a member of the actin-binding proteins superfamily that is thought to cross-link actin filaments. As summarized in [Table](#T1){ref-type="table"}, a library plasmid encoding for Pro^355^--Leu^892^ of α-actinin did not activate β-galactosidase by itself, when coexpressed with the empty GAL4BD vector, or with unrelated control plasmids. Conversely, it strongly interacted with the CARD of bcl10. However, both wild-type and mutant forms of bcl10 bind similarly to α-actinin in yeast and in vitro ([Table](#T1){ref-type="table"} and [Fig. 6](#F6){ref-type="fig"} A). Together with cytochalasin D experiments, the two-hybrid data suggest that interaction of bcl10 with cytoskeleton components is necessary, but not sufficient for filament formation.

Next, we tested whether filament formation could result from bcl10 multimerization. Immunoprecipitation analysis shown in [Fig. 6](#F6){ref-type="fig"} B revealed that wild-type bcl10 self-associates via a CARD-mediated homophilic interaction, however, both mutants bcl10(L41Q) and bcl10(G78R) did not dimerize, suggesting that bcl10 filaments result from self-assembly. Thus, both dimerization of bcl10 and binding to α-actinin are necessary for filament formation and NF-κB activation.

bcl10 is expressed in many normal tissues and overexpression of the gene causes cellular transformation ([Willis et al. 1999](#Willisetal1999){ref-type="bib"}; [Zhang et al. 1999](#Zhangetal1999){ref-type="bib"}). Therefore, we tested whether filamentous organization of bcl10 and deregulated NF-κB activation both derive from disregulated level of expression of the protein. Indeed, in Rat-2 cells, endogenous bcl10 displays a diffuse cytosolic distribution, whereas overexpression of the gene induces filament formation and NF-κB activation ([Fig. 7](#F7){ref-type="fig"}). These results, however, do not exclude the possibility that local micro-assembling of the protein may physiologically occur in normal conditions or after specific stimulation.

Independent evidence suggests that the transforming capability of bcl10 is the result of a nonreceptor-mediated NF-κB activation arising from deregulated expression of the gene ([Willis et al. 1999](#Willisetal1999){ref-type="bib"}; [Zhang et al. 1999](#Zhangetal1999){ref-type="bib"}). In the present study, we have shown that organization of bcl10 into ordered structures is essential for NF-κB--inducing activity of the protein. Similarly to scaffolding and anchoring proteins that determine selective activation of mitogen-activated protein kinases by sequestration and localization of signaling complexes, filamentous arrangement of bcl10 is required for recruitment of TRADD, and may be essential for local concentration and activation of other downstream signaling proteins. Hence, as recruitment of TRADD to TNF-RI complex initiates a signal transduction pathway leading to NF-κB activation, the same signaling pathway can be activated upon TRADD recruitment to different cellular compartments.

Cytoskeletal-like shape of bcl10 filaments and direct interaction of bcl10 with cytoskeletal proteins suggest that cytoskeleton dynamics may regulate bcl10 signaling. Indeed, activation of the NF-κB transcription factors is directly influenced by changes in the cytoskeleton network ([Rosette and Karin 1995](#RosetteandKarin1995){ref-type="bib"}). bcl10 filaments resemble the death-effector filaments, cytoplasmic filaments that sequester and activate procaspase zymogens ([Perez and White 1998](#PerezandWhite1998){ref-type="bib"}; [Siegel et al. 1998](#Siegeletal1998){ref-type="bib"}), and similar structures are formed when the CARD of caspase-2 is overexpressed ([Colussi et al. 1998](#Colussietal1998){ref-type="bib"}). Generation of death-effector filaments is essential for activation of a signaling cascade leading to cellular apoptosis, and inhibition of filament formation prevents cell death. Thus, formation of ordered assembly of protein may represent a general mechanism for receptor-independent activation of specific signal transduction pathways.
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###### 

Specificity of the Interaction between bcl10 and Cytoskeleton Proteins

  Protein fused to GAL4 domain   β-Galactosidasefilter assay   Liquid assay   
  ------------------------------ ----------------------------- -------------- --------------
                                                                              Miller units
  --                             α-Actinin                     White          0.04 ± 0.02
  Vector                         α-Actinin                     White          0.03 ± 0.01
  pLAM5                          α-Actinin                     White          0.03 ± 0.01
  bcl10                          α-Actinin                     Blue           0.40 ± 0.03
  DR4                            α-Actinin                     White          0.01 ± 0.01
  Flice                          α-Actinin                     White          0.02 ± 0.02
  Fadd                           α-Actinin                     White          0.01 ± 0.00
  bcl10L41Q                      α-Actinin                     Blue           0.32 ± 0.04
  bcl10G78R                      α-Actinin                     Blue           0.44 ± 0.02
  mut 6                          α-Actinin                     Blue           0.36 ± 0.02
  mut 9                          α-Actinin                     Blue           0.40 ± 0.80
  mut 11                         α-Actinin                     Blue           0.24 ± 0.03
  bcl10                          --                            White          0.01 ± 0.00

HF7c cells were cotransformed with vectors encoding for the indicated polypeptides fused to GAL4 DNA-binding domain and GAL4 transcriptional activation domain. Filter and liquid assays for β-galactosidase activity are shown. Yeast colonies were scored as positive when a bright color developed within 2--5 h, a negative colony was scored when color failed to develop within 12 h. Assays were done for 5--10 independent transformants.

###### 

Subcellular localization of bcl10. HeLa cells were transfected with mammalian HA-tagged vector, empty (A) or expressing bcl10 (B). 16 h after transfection, cells were stained with anti-HA mAb, followed by FITC-conjugated anti-mouse IgG. C, Immunoblot analysis of proteic lysates from 293 cells transfected with FLAG-tagged vector, empty or expressing bcl10. Membranes were probed with anti-FLAG mAb or with two different anti-bcl10 affinity-purified rabbit antisera generated against the polypeptides Arg^58^--Glu^74^ (Ab-1) and Phe^125^--Lys^146^ (Ab-2), followed by HRP-conjugated secondary mAb. D, HeLa cells transfected with bcl10 were stained with anti-bcl10 antisera (Ab-1), followed by FITC-conjugated anti-rabbit IgG. Similar results were obtained when the staining was done with Ab-2.
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###### 

Mutations in the CARD abolish filament formation and NF-κB activation. A, Fluorescence confocal micrographs of bcl10 mutants. HeLa cells expressing bcl10^128-233^, bcl10^1-127^, bcl10(L41Q), and bcl10(G78R) were stained with anti-HA mAb followed by FITC-conjugated anti-mouse IgG. B, HeLa cells were cotransfected with pNF-κB-luc, pCMV-β-gal, and an equal amount of the indicated bcl10 mutant. Data represent relative luciferase activity normalized for β-galactosidase expression and is representative of three independent triplicate experiments. C, HeLa cells expressing bcl10 together with dominant negative versions of IκB (right) or NIK (left) were stained with anti-HA mAb, followed by FITC-conjugated anti-mouse IgG.
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###### 

bcl10 filaments correlate with NF-κB activation. A, PCR-based randomly mutagenized versions of bcl10 were transfected in HeLa cells and assayed for filament formation and NF-κB activation as described in [Fig. 2](#F2){ref-type="fig"}. Amino acids in bold represent sequence identity or conservative substitutions through the CARD regions of Apaf1, ARC, Raidd, c-IAP-1, c-IAP-2, cardiak, caspase-1, caspase-2, caspase-4, caspase-5, caspase-9, ced3 and ced4. (B) bcl10 mutants were scored positive for filament formation when filaments were detected in \>60% of transfected cells; bcl10 mutants were scored positive for NF-κB activation when luciferase activity was at least threefold higher than control vector in two independent triplicate experiments. Similar results were obtained with an additional 15 mutant versions of bcl10 (data not shown).
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###### 

Recruitment of TRADD and RIP into bcl10 filaments. A, HeLa cells expressing bcl10 and FLAG-tagged TRADD were costained with anti-bcl10, followed by FITC-conjugated anti-rabbit IgG (green fluorescence) and anti-FLAG followed by rhodamine-conjugated anti-mouse IgG (red fluorescence). Overlay of the two channels generate a yellow overlapping fluorescence. B, HeLa cells untreated (left) or transfected with bcl10 (right), were stained with anti-TRADD antibody followed by FITC-conjugated anti-rabbit IgG. C, HeLa cells transfected with HA-tagged bcl10 were costained with anti-bcl10, followed by FITC-conjugated anti-mouse IgG (green fluorescence) and anti-Tradd, followed by rhodamine-conjugated anti-rabbit IgG (red fluorescence). Overlay of the two channels generate a yellow overlapping fluorescence. D, HeLa cells transiently transfected with bcl10 were stained with anti-RIP antibody, followed by FITC-conjugated anti-rabbit IgG.
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###### 

Cytochalasin D disassembles bcl10 filament and bcl10-induced NF-κB activation. HeLa cells were cultured in presence of cytochalasin D (20 μM) for the indicated time and bcl10 distribution (A) and NF-κB activation (B) were determined as described in Materials and Methods. Data presented in B is representative of three independent triplicate experiments.
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![A, In vitro binding of bcl10 with α-actinin. Histidine-tagged bcl10 proteins were purified on agarose beads and mixed with 5 μg of recombinant α-actinin. Beads were washed, boiled in SDS-sample buffer, resolved by SDS-PAGE, and transferred on nitrocellulose membrane subsequently probed with anti--α-actinin, followed by HRP-conjugated secondary mAb. Agarose-immobilized TRAIL served as control for nonspecific binding. A fraction of the reaction mixtures was stained with Coomassie and aligned to visualize histidine-tagged proteins. B, Mutations in the CARD abolish bcl10 dimerization. 293 cells were transfected with the full-length or a truncated CARD-containing version of bcl10 together with the indicated cDNAs expressed in pCMV-FLAG. After transfection, samples were immunoprecipitated with anti-HA mAb and analyzed for coprecipitating proteins by immunoblotting, followed by probing with anti-FLAG mAb.](JCB9911117.f6){#F6}

###### 

Cellular localization of endogenous bcl10. A, Immunoblot analysis of proteic lysate from Rat-2 cells. 10 μg of total cell lysate was resolved by SDS-PAGE and transferred onto nitrocellulose membrane probed with anti-bcl10 antisera, followed by HRP-conjugated secondary mAb. B, Left, Confocal image of Rat-2 cells stained with anti-bcl10 antisera (Ab-1), followed by FITC-conjugated anti-rabbit IgG. Right, Rat-2 cells transfected with bcl10^1-127^ were stained with anti-bcl10 (Ab-1), followed by FITC-conjugated anti-rabbit IgG. C, Rat-2 cells were cotransfected with pNF-κB-luc, together with bcl10^1-127^ or empty plasmid. Data represent relative luciferase activity and is representative of two independent triplicate experiments.

![](JCB9911117.f7a)

![](JCB9911117.f7b)

![](JCB9911117.f7c)
